Search

everythinglearnresearchcommunity

for

Search:↓

Et-BB3-CMU rice bran extract may be a promising natural option for promoting hair growth and preventing hair loss.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

Collagen VII helps skin heal and stay strong, sirolimus may lower skin cancer risk in kidney transplant patients, high-molecular-mass hyaluronan helps naked mole rats resist cancer, dermal γδ T cells aid in hair growth in rodents, and overexpression of IL-33 in mouse skin causes itchiness, offering a model for studying allergic inflammation treatments.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

ERG increases SOX9, promoting prostate cancer growth and invasion.

Targeted cancer therapies often cause serious skin problems that need careful management.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Smoking harms the skin, causing early aging and increasing cancer risk, but stopping smoking can improve skin health.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Iranian veterans exposed to sulfur mustard suffer from long-term skin itching and eye damage, with some risk of skin cancer and ongoing management challenges.

The Hedgehog signaling pathway is important for skin and hair growth and can lead to cancer if it doesn't work right.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

There is no clear recommendation for using selenium in cancer patients; it may be beneficial to correct low selenium levels before treatment.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

First Korean case of Cronkhite-Canada syndrome with colon cancer and serrated adenoma.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

A cancer patient's hair became permanently curly after treatment with nivolumab.

The cancer drugs bortezomib and lenalidomide cause skin side effects in many patients.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.